Cochlear Implant Market - Global Forecast To 2030
商品番号 : SMB-73318
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年2月 |
| ページ数 | 216 |
| 図表数 | 223 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global cochlear implants market is valued at an estimated 2.80 billion in 2024 and is projected to reach USD 4.73 billion by 2030, at a CAGR of 9.2% during the forecast period. With the global increase in aging populations, age-related hearing loss (presbycusis) is becoming more common, creating a larger pool of potential candidates for cochlear implantation.
世界の人工内耳市場は、2024 年に推定 28 億米ドルと評価され、予測期間中の CAGR 9.2% で、2030 年までに 47 億 3000 万米ドルに達すると予測されています。高齢化人口の世界的な増加に伴い、加齢に伴う難聴（老人性難聴）がより一般的になってきており、人工内耳の潜在的な候補者がさらに多くなっています。
WHO-reported data suggests that over 1.5 billion people-just under 20% of the global population-with hearing loss existed, of which around 430 million have disabling hearing loss, and are expected to rise by more than double-750 million in 2050. The main driver of these growth factors, the rising incidence of hearing problems, fuels further demand for CI.
WHOが報告したデータによると、世界人口の20％弱に当たる15億人以上が難聴を抱えており、そのうち約4億3,000万人が障害性難聴を抱えており、2050年には2倍の7億5,000万人以上増加すると予想されている。これらの成長要因の主な原動力である聴覚障害の発生率の上昇が、CIの需要をさらに高めている。
In 2023, the pediatric segment accounted for the largest share of the cochlear implants market, by patient type.
Adults and pediatrics make up the patient type-based segments of the cochlear implants market. Market share for cochlear implants was highest in the peadiatrics in 2023. This is mainly due to the high incidence of hearing loss in children, increasing technological advancements, early diagnosis of hearing impairments through newborn screening programs, and growing awareness among parents about the benefits of early intervention.
“The hospitals segment is projected to witness the highest growth rate in the cochlear implants market, by end user, during the forecast period.”
Based on end user, the cochlear implants market is segmented into hospitals, ENT clinics, and other end users. The driving factors that force hospitals to adopt cochlear implants include better patient outcomes, a multidisciplinary team approach, and novel surgical technologies. Besides, investment in hospital infrastructure-especially within emerging markets-and insurance cover for cochlear implants ensure better access and, consequently, better affordability of cochlear implants, increasing their demand in the hospital environment.
“The Asia Pacific region is projected to witness highest growth rate in the cochlear implants market during the forecast period”
The global cochlear implants market is segmented into six regions – North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the cochlear implants market is expected to grow at the fastest rate in the Asia Pacific region. The demand for cochlear implants in the APAC is mainly driven by the growing geriatric population, the increasing GDP of Asian countries, the rising healthcare expenditure in the APAC countries, and growing public awareness.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: C-level – 27%, D-level – 18%, and Others – 55%
- By Region: North America – 35%, Europe – 31%, Asia Pacific – 22%, Latin America – 9%, Middle East & Africa – 2%, and the GCC Countries – 1%
Lists of Companies Profiled in the Report:
Cochlear Ltd. (Australia), Sonova (Switzerland), MED-EL Medical Electronics (Austria), Zhejiang Nurotron Biotechnology Co., Ltd. (China), Neubio AG (Switzerland), TODOC Co., Ltd. (South Korea), and Shanghai Listent Medical Tech Co., Ltd. (China).
Research Coverage:
In this report, the cochlear implants market has been categorized based on type of implants (unilateral implants, bilateral implants), end user (hospitals, ENT clinics, and other end users), patient type (adults, pediatrics), component type (cochlear implant systems, upgrades & accessories), and region (Europe, Middle East & Africa, North America, Latin America, Asia Pacific, and the GCC Countries).
Comprehensive information regarding the main drivers, barriers, opportunities, and challenges influencing the cochlear implants market’s expansion is included in detail in this study. An exhaustive study of the key players in the cochlear implants market has been done to provide insights into their business profile, products offered, noteworthy strategies, product launches and approvals, and other recent activities pertaining to the market.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall cochlear implants market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, challenges, opportunities, and restaints.
The report provides insights on the following pointers:
- Analysis of key drivers: (Rising prevalence of hearing impairment, growing geriatric population, and comprehensive insurance coverage and favorable reimbursement policies), restraints (High cost of cochlear implants and associated surgeries and surgical risks, procedural complications, and long post-surgery rehabilitation), opportunities (Lucrative growth opportunities in emerging economies, technological innovations in cochlear implants, and integration with digital health platforms), and challenges (Shortage of skilled professionals performing ENT procedures, competition from alternative solutions) influencing the growth of the in cochlear implants market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the cochlear implants market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cochlear implants market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Cochlear Ltd. (Australia), Sonova (Switzerland), and MED-EL Medical Electronics (Austria) are among others, in the cochlear implants market strategies.
Table of Contents
1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.3 STUDY SCOPE 23
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD 23
1.3.2 INCLUSIONS & EXCLUSIONS 24
1.3.3 YEARS CONSIDERED 24
1.3.4 CURRENCY CONSIDERED 25
1.4 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH DATA 26
2.1.1 SECONDARY DATA 27
2.1.1.1 Key sources for secondary data 27
2.1.1.2 Key data from secondary sources 28
2.1.2 PRIMARY DATA 28
2.1.2.1 Key primary sources 29
2.1.2.2 Objectives of primary research 29
2.1.2.3 Key data from primary sources 30
2.1.2.4 Key industry insights 31
2.1.2.5 Breakdown of primaries 31
2.2 MARKET SIZE ESTIMATION 32
2.2.1 BOTTOM-UP APPROACH 32
2.2.1.1 Company revenue estimation approach 33
2.2.1.1.1 Presentations of companies and primary interviews 33
2.2.1.1.2 Primary interviews 34
2.2.1.1.3 Country-based approach for estimating global market size 34
2.2.1.1.4 Approach for estimating global market size based on
units sold 35
2.2.2 TOP-DOWN APPROACH 37
2.3 DATA TRIANGULATION 38
2.4 MARKET SHARE ANALYSIS 39
2.5 STUDY ASSUMPTIONS 39
2.5.1 MARKET ASSUMPTIONS 39
2.5.2 GROWTH RATE ASSUMPTIONS 39
2.6 RESEARCH LIMITATIONS 40
2.6.1 METHODOLOGY-RELATED LIMITATIONS 40
2.6.2 SCOPE-RELATED LIMITATIONS 40
2.7 RISK ASSESSMENT 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 45
4.1 COCHLEAR IMPLANTS MARKET OVERVIEW 45
4.2 NORTH AMERICA: COCHLEAR IMPLANTS MARKET,
BY COMPONENT TYPE AND COUNTRY (2023) 46
4.3 COCHLEAR IMPLANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
4.4 COCHLEAR IMPLANTS MARKET: REGIONAL MIX (2024–2030) 48
4.5 COCHLEAR IMPLANTS MARKET: DEVELOPED VS. EMERGING ECONOMIES 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
5.2.1 DRIVERS 50
5.2.1.1 Rising prevalence of hearing impairment 50
5.2.1.2 Growing geriatric population 51
5.2.1.3 Comprehensive insurance coverage and favorable reimbursement policies 52
5.2.2 RESTRAINTS 53
5.2.2.1 High cost of cochlear implants and associated surgeries 53
5.2.2.2 Surgical risks, procedural complications, and long post-surgery rehabilitation 54
5.2.3 OPPORTUNITIES 55
5.2.3.1 Lucrative growth opportunities in emerging economies 55
5.2.3.2 Technological innovations in cochlear implants 56
5.2.3.3 Integration with digital health platforms 56
5.2.4 CHALLENGES 57
5.2.4.1 Shortage of skilled professionals performing ENT procedures 57
5.2.4.2 Competition from alternative solutions 58
5.3 PRICING ANALYSIS 58
5.3.1 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT SYSTEMS,
BY REGION, 2021–2023 58
5.3.2 AVERAGE SELLING PRICE TREND COCHLEAR IMPLANT PRODUCTS,
BY KEY PLAYER, 2021–2023 59
5.4 VALUE CHAIN ANALYSIS 61
5.5 SUPPLY CHAIN ANALYSIS 62
5.6 ECOSYSTEM ANALYSIS 63
5.6.1 ROLE IN ECOSYSTEM 64
5.7 PORTER’S FIVE FORCES ANALYSIS 65
5.7.1 THREAT OF NEW ENTRANTS 66
5.7.2 THREAT OF SUBSTITUTES 66
5.7.3 BARGAINING POWER OF BUYERS 66
5.7.4 BARGAINING POWER OF SUPPLIERS 66
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 67
5.8 KEY STAKEHOLDERS & BUYING CRITERIA 67
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 67
5.8.2 KEY BUYING CRITERIA 68
5.9 REGULATORY ANALYSIS 68
5.9.1 REGULATORY FRAMEWORK 68
5.9.1.1 North America 68
5.9.1.1.1 US 68
5.9.1.1.2 Canada 70
5.9.1.2 Europe 70
5.9.1.3 Asia Pacific 71
5.9.1.3.1 Japan 71
5.9.1.3.2 China 71
5.9.1.3.3 India 72
5.9.1.4 Latin America 72
5.9.1.4.1 Brazil 72
5.9.1.4.2 Mexico 73
5.9.1.5 Middle East 73
5.9.1.6 Africa 73
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
5.10 TRADE ANALYSIS 75
5.10.1 IMPORT DATA FOR HS CODE 902140 75
5.10.2 EXPORT DATA FOR HS CODE 902140 76
5.11 PATENT ANALYSIS 77
5.11.1 LIST OF MAJOR PATENTS 78
5.12 KEY CONFERENCES & EVENTS, 2025–2026 79
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 81
5.14 TECHNOLOGY ANALYSIS 81
5.14.1 KEY TECHNOLOGIES 81
5.14.1.1 Electrode-based auditory nerve stimulation 81
5.14.2 COMPLEMENTARY TECHNOLOGIES 82
5.14.2.1 Bimodal hearing solutions 82
5.14.3 ADJACENT TECHNOLOGIES 82
5.14.3.1 Bone conduction hearing devices 82
5.15 INVESTMENT & FUNDING SCENARIO 82
5.16 IMPACT OF AI/GEN AI ON COCHLEAR IMPLANTS MARKET 83
6 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE 84
6.1 INTRODUCTION 85
6.2 COCHLEAR IMPLANT SYSTEMS 85
6.2.1 INCREASED GERIATRIC POPULATION AND AVAILABILITY OF MEDICAL INSURANCE TO BOOST MARKET GROWTH 85
6.3 UPGRADES & ACCESSORIES 89
6.3.1 FOCUS ON TECHNOLOGICAL INNOVATIONS AND DEVICE PERSONALIZATION TO PROPEL MARKET GROWTH 89
7 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT 93
7.1 INTRODUCTION 94
7.2 UNILATERAL IMPLANTS 94
7.2.1 BETTER INSURANCE COVERAGE TO AID ADOPTION OF UNILATERAL IMPLANTS IN PATIENTS 94
7.3 BILATERAL IMPLANTS 97
7.3.1 IMPROVED SOUND LOCALIZATION AND SPEECH COMPREHENSION IN NOISY ENVIRONMENTS AMONG CHILDREN TO AUGMENT GROWTH 97
8 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE 101
8.1 INTRODUCTION 102
8.2 ADULTS 102
8.2.1 HIGHER SUSCEPTIBILITY TO HEARING LOSS IN GERIATRIC POPULATION TO FUEL ADOPTION OF COCHLEAR IMPLANTS 102
8.3 PEDIATRICS 105
8.3.1 EARLY DIAGNOSIS OF HEARING IMPAIRMENTS THROUGH NEWBORN SCREENING PROGRAMS TO SUPPORT MARKET GROWTH 105
9 COCHLEAR IMPLANTS MARKET, BY END USER 110
9.1 INTRODUCTION 111
9.2 HOSPITALS 111
9.2.1 INCREASED ACCESS TO ADVANCED DIAGNOSTIC EQUIPMENT AND PRESENCE OF SKILLED SURGICAL TEAMS TO AID MARKET GROWTH 111
9.3 ENT CLINICS 114
9.3.1 INCREASING AWARENESS OF ENT-RELATED ISSUES AND GROWING NETWORK OF ADVANCED CLINICS TO AID GROWTH 114
9.4 OTHER END USERS 117
10 COCHLEAR IMPLANTS MARKET, BY REGION 121
10.1 INTRODUCTION 122
10.2 NORTH AMERICA 123
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 123
10.2.2 US 126
10.2.2.1 US to dominate North American cochlear implants market during study period 126
10.2.3 CANADA 129
10.2.3.1 Growing geriatric population and rising government health expenditure to propel market growth 129
10.3 EUROPE 132
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 132
10.3.2 GERMANY 135
10.3.2.1 High incidence of hearing impairment and favorable government health insurance schemes to augment growth 135
10.3.3 UK 137
10.3.3.1 Increased prevalence of hearing problems among older adults to boost market growth 137
10.3.4 FRANCE 139
10.3.4.1 Need for advanced treatment options and high government healthcare expenditure to spur market adoption 139
10.3.5 ITALY 141
10.3.5.1 Well-developed healthcare system with high financial resources to fuel uptake of cochlear implants 141
10.3.6 SPAIN 143
10.3.6.1 Long waiting times for ENT appointments and lack of reimbursement to limit market growth 143
10.3.7 REST OF EUROPE 145
10.4 ASIA PACIFIC 148
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 148
10.4.2 JAPAN 151
10.4.2.1 Advanced healthcare system and rapidly growing geriatric population to support market growth 151
10.4.3 CHINA 154
10.4.3.1 Modernization of healthcare facilities and increased patient pool to drive market 154
10.4.4 INDIA 156
10.4.4.1 Higher incidence of hearing impairment and increased government funds to propel market growth 156
10.4.5 AUSTRALIA 158
10.4.5.1 Increasing number of ENT specialists and rising government funding in public hospitals to support market growth 158
10.4.6 REST OF ASIA PACIFIC 161
10.5 LATIN AMERICA 163
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 163
10.5.2 BRAZIL 166
10.5.2.1 Favorable investment scenario from medical device manufacturers to favor market growth 166
10.5.3 MEXICO 168
10.5.3.1 Increased FDI and growing presence of key healthcare companies to support market growth 168
10.5.4 REST OF LATIN AMERICA 170
10.6 MIDDLE EAST & AFRICA 172
10.6.1 FOCUS ON HEALTHCARE SYSTEM MODERNIZATION AND INCREASED GOVERNMENT AWARENESS TO DRIVE MARKET 172
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 173
10.7 GCC COUNTRIES 175
10.7.1 EMPHASIS ON INFRASTRUCTURAL DEVELOPMENT AND HEALTHCARE ACCESS TO SUPPORT MARKET GROWTH 175
10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 176
11 COMPETITIVE LANDSCAPE 178
11.1 INTRODUCTION 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN COCHLEAR IMPLANTS MARKET 178
11.3 REVENUE ANALYSIS, 2021–2023 180
11.4 MARKET SHARE ANALYSIS, 2023 181
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 183
11.5.1 STARS 183
11.5.2 EMERGING LEADERS 183
11.5.3 PERVASIVE PLAYERS 183
11.5.4 PARTICIPANTS 183
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 185
11.5.5.1 Company footprint 185
11.5.5.2 Region footprint 185
11.5.5.3 Component type footprint 186
11.5.5.4 Patient type footprint 186
11.5.5.5 End-user footprint 187
11.6 COMPANY VALUATION & FINANCIAL METRICS 187
11.7 BRAND/PRODUCT COMPARISON 188
11.8 COMPETITIVE SCENARIO 189
11.8.1 PRODUCT LAUNCHES & APPROVALS 189
11.8.2 DEALS 190
11.8.3 OTHER DEVELOPMENTS 190
12 COMPANY PROFILES 191
12.1 KEY PLAYERS 191
12.1.1 COCHLEAR LTD. 191
12.1.1.1 Business overview 191
12.1.1.2 Products offered 192
12.1.1.3 Recent developments 194
12.1.1.3.1 Product launches & approvals 194
12.1.1.3.2 Deals 194
12.1.1.4 MnM view 195
12.1.1.4.1 Key strengths 195
12.1.1.4.2 Strategic choices 195
12.1.1.4.3 Weaknesses & competitive threats 195
12.1.2 SONOVA 196
12.1.2.1 Business overview 196
12.1.2.2 Products offered 198
12.1.2.3 Recent developments 198
12.1.2.3.1 Other developments 198
12.1.2.4 MnM view 199
12.1.2.4.1 Key strengths 199
12.1.2.4.2 Strategic choices 199
12.1.2.4.3 Weaknesses & competitive threats 199
12.1.3 MED-EL MEDICAL ELECTRONICS 200
12.1.3.1 Business overview 200
12.1.3.2 Products offered 200
12.1.3.3 Recent developments 201
12.1.3.3.1 Product launches 201
12.1.3.3.2 Deals 201
12.1.3.3.3 Other developments 202
12.1.3.4 MnM view 202
12.1.3.4.1 Key strengths 202
12.1.3.4.2 Strategic choices 202
12.1.3.4.3 Weaknesses & competitive threats 202
12.1.4 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD. 203
12.1.4.1 Business overview 203
12.1.4.2 Products offered 203
12.1.5 NEUBIO AG 205
12.1.5.1 Business overview 205
12.1.5.2 Products offered 205
12.1.6 TODOC CO., LTD. 206
12.1.6.1 Business overview 206
12.1.6.2 Products offered 206
12.1.7 SHANGHAI LISTENT MEDICAL TECH CO., LTD. 207
12.1.7.1 Business overview 207
12.1.7.2 Products offered 207
13 APPENDIX 208
13.1 DISCUSSION GUIDE 208
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 212
13.3 CUSTOMIZATION OPTIONS 214
13.4 RELATED REPORTS 214
13.5 AUTHOR DETAILS 215
LIST OF TABLES
TABLE 1 COCHLEAR IMPLANTS MARKET: INCLUSIONS & EXCLUSIONS 24
TABLE 2 COCHLEAR IMPLANTS MARKET: KEY DATA FROM PRIMARY SOURCES 30
TABLE 3 COCHLEAR IMPLANTS MARKET: MARKET ASSUMPTIONS 39
TABLE 4 COCHLEAR IMPLANTS MARKET: RISK ASSESSMENT 40
TABLE 5 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION,
2023 VS. 2030 VS. 2050 52
TABLE 6 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT SYSTEMS,
BY REGION, 2021–2023 59
TABLE 7 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT PRODUCTS,
BY KEY PLAYER, 2021–2023 60
TABLE 8 COCHLEAR IMPLANTS MARKET: ROLE IN ECOSYSTEM 64
TABLE 9 COCHLEAR IMPLANTS MARKET: PORTER’S FIVE FORCES 65
TABLE 10 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%) 67
TABLE 11 KEY BUYING CRITERIA FOR MAJOR END USERS 68
TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION 69
TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 69
TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 70
TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 71
TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES 72
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 21 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 22 IMPORT DATA FOR HS CODE 902140, BY COUNTRY,
2019–2023 (USD THOUSAND) 75
TABLE 23 EXPORT DATA FOR HS CODE 902140, BY COUNTRY,
2019–2023 (USD THOUSAND) 76
TABLE 24 COCHLEAR IMPLANTS MARKET: LIST OF MAJOR PATENTS 78
TABLE 25 COCHLEAR IMPLANTS MARKET: LIST OF KEY CONFERENCES & EVENTS,
JANUARY 2025–DECEMBER 2026 79
TABLE 26 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 85
TABLE 27 KEY COCHLEAR IMPLANT SYSTEMS AVAILABLE IN MARKET 86
TABLE 28 COCHLEAR IMPLANT SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION) 87
TABLE 29 NORTH AMERICA: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 87
TABLE 30 EUROPE: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 88
TABLE 31 ASIA PACIFIC: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 88
TABLE 32 LATIN AMERICA: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 89
TABLE 33 KEY COCHLEAR IMPLANT UPGRADES & ACCESSORIES AVAILABLE IN MARKET 90
TABLE 34 COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY REGION,
2022–2030 (USD MILLION) 90
TABLE 35 NORTH AMERICA: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 91
TABLE 36 EUROPE: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 91
TABLE 37 ASIA PACIFIC: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 92
TABLE 38 LATIN AMERICA: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET,
BY COUNTRY, 2022–2030 (USD MILLION) 92
TABLE 39 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 94
TABLE 40 COCHLEAR UNILATERAL IMPLANTS MARKET, BY REGION,
2022–2030 (USD MILLION) 95
TABLE 41 NORTH AMERICA: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 95
TABLE 42 EUROPE: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 96
TABLE 43 ASIA PACIFIC: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 96
TABLE 44 LATIN AMERICA: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 97
TABLE 45 COCHLEAR BILATERAL IMPLANTS MARKET, BY REGION,
2022–2030 (USD MILLION) 98
TABLE 46 NORTH AMERICA: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 98
TABLE 47 EUROPE: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 99
TABLE 48 ASIA PACIFIC: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 99
TABLE 49 LATIN AMERICA: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 100
TABLE 50 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 102
TABLE 51 COCHLEAR IMPLANTS MARKET FOR ADULTS, BY REGION,
2022–2030 (USD MILLION) 103
TABLE 52 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022–2030 (USD MILLION) 104
TABLE 53 EUROPE: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY,
2022–2030 (USD MILLION) 104
TABLE 54 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY,
2022–2030 (USD MILLION) 105
TABLE 55 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022–2030 (USD MILLION) 105
TABLE 56 COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY REGION,
2022–2030 (USD MILLION) 107
TABLE 57 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022–2030 (USD MILLION) 107
TABLE 58 EUROPE: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY,
2022–2030 (USD MILLION) 108
TABLE 59 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022–2030 (USD MILLION) 108
TABLE 60 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022–2030 (USD MILLION) 109
TABLE 61 COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 111
TABLE 62 COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY REGION,
2022–2030 (USD MILLION) 112
TABLE 63 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 113
TABLE 64 EUROPE: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY,
2022–2030 (USD MILLION) 113
TABLE 65 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 114
TABLE 66 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 114
TABLE 67 COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY REGION,
2022–2030 (USD MILLION) 115
TABLE 68 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 115
TABLE 69 EUROPE: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY,
2022–2030 (USD MILLION) 116
TABLE 70 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 116
TABLE 71 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 117
TABLE 72 COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY REGION,
2022–2030 (USD MILLION) 118
TABLE 73 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS,
BY COUNTRY, 2022–2030 (USD MILLION) 118
TABLE 74 EUROPE: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 119
TABLE 75 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS,
BY COUNTRY, 2022–2030 (USD MILLION) 119
TABLE 76 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS,
BY COUNTRY, 2022–2030 (USD MILLION) 120
TABLE 77 HEARING AIDS SOLD GLOBALLY, 2022–2030 (MILLION UNITS) 122
TABLE 78 COCHLEAR IMPLANTS MARKET, BY REGION, 2022–2030 (USD MILLION) 122
TABLE 79 NORTH AMERICA: MACROECONOMIC INDICATORS 124
TABLE 80 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 125
TABLE 81 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 125
TABLE 82 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 125
TABLE 83 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030(USD MILLION) 126
TABLE 84 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 126
TABLE 85 US: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 128
TABLE 86 US: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 128
TABLE 87 US: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 129
TABLE 88 US: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 129
TABLE 89 CANADA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 131
TABLE 90 CANADA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 131
TABLE 91 CANADA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 131
TABLE 92 CANADA: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 132
TABLE 93 EUROPE: MACROECONOMIC INDICATORS 133
TABLE 94 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 133
TABLE 95 EUROPE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 133
TABLE 96 EUROPE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 134
TABLE 97 EUROPE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 134
TABLE 98 EUROPE: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 134
TABLE 99 GERMANY: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 136
TABLE 100 GERMANY: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 136
TABLE 101 GERMANY: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 136
TABLE 102 GERMANY: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 137
TABLE 103 UK: NUMBER OF NEW COCHLEAR IMPLANT RECIPIENTS 138
TABLE 104 UK: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 138
TABLE 105 UK: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 138
TABLE 106 UK: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 139
TABLE 107 UK: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 139
TABLE 108 FRANCE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 140
TABLE 109 FRANCE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 140
TABLE 110 FRANCE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 141
TABLE 111 FRANCE: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 141
TABLE 112 ITALY: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 142
TABLE 113 ITALY: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 142
TABLE 114 ITALY: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 143
TABLE 115 ITALY: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 143
TABLE 116 SPAIN: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 144
TABLE 117 SPAIN: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 144
TABLE 118 SPAIN: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 145
TABLE 119 SPAIN: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 145
TABLE 120 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 146
TABLE 121 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 146
TABLE 122 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 147
TABLE 123 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 147
TABLE 124 ASIA PACIFIC: MACROECONOMIC INDICATORS 148
TABLE 125 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 150
TABLE 126 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 150
TABLE 127 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 150
TABLE 128 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 151
TABLE 129 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 151
TABLE 130 JAPAN: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 152
TABLE 131 JAPAN: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 153
TABLE 132 JAPAN: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 153
TABLE 133 JAPAN: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 153
TABLE 134 CHINA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 154
TABLE 135 CHINA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 155
TABLE 136 CHINA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 155
TABLE 137 CHINA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 155
TABLE 138 INDIA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 157
TABLE 139 INDIA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 157
TABLE 140 INDIA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 158
TABLE 141 INDIA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 158
TABLE 142 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 159
TABLE 143 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 160
TABLE 144 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 160
TABLE 145 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 160
TABLE 146 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 162
TABLE 147 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 162
TABLE 148 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 162
TABLE 149 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 163
TABLE 150 LATIN AMERICA: MACROECONOMIC INDICATORS 164
TABLE 151 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 164
TABLE 152 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 164
TABLE 153 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 165
TABLE 154 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 165
TABLE 155 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 165
TABLE 156 BRAZIL: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 166
TABLE 157 BRAZIL: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 167
TABLE 158 BRAZIL: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 167
TABLE 159 BRAZIL: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 167
TABLE 160 MEXICO: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 168
TABLE 161 MEXICO: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 169
TABLE 162 MEXICO: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 169
TABLE 163 MEXICO: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 169
TABLE 164 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 170
TABLE 165 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 171
TABLE 166 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 171
TABLE 167 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 171
TABLE 168 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 173
TABLE 169 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 173
TABLE 170 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 174
TABLE 171 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 174
TABLE 172 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 174
TABLE 173 GCC COUNTRIES: MACROECONOMIC INDICATORS 176
TABLE 174 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2022–2030 (USD MILLION) 176
TABLE 175 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2022–2030 (USD MILLION) 176
TABLE 176 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE,
2022–2030 (USD MILLION) 177
TABLE 177 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY END USER,
2022–2030 (USD MILLION) 177
TABLE 178 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS
IN COCHLEAR IMPLANTS MARKET 178
TABLE 179 COCHLEAR IMPLANTS MARKET: DEGREE OF COMPETITION 181
TABLE 180 COCHLEAR IMPLANTS MARKET: REGION FOOTPRINT 185
TABLE 181 COCHLEAR IMPLANTS MARKET: COMPONENT TYPE FOOTPRINT 186
TABLE 182 COCHLEAR IMPLANTS MARKET: PATIENT TYPE FOOTPRINT 186
TABLE 183 COCHLEAR IMPLANTS MARKET: END-USER FOOTPRINT 187
TABLE 184 COCHLEAR IMPLANTS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–DECEMBER 2024 189
TABLE 185 COCHLEAR IMPLANTS MARKET: DEALS, JANUARY 2021–DECEMBER 2024 190
TABLE 186 COCHLEAR IMPLANTS MARKET: OTHER DEVELOPMENTS,
JANUARY 2021–DECEMBER 2024 190
TABLE 187 COCHLEAR LTD.: COMPANY OVERVIEW 191
TABLE 188 COCHLEAR LTD.: PRODUCTS OFFERED 192
TABLE 189 COCHLEAR LTD.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–DECEMBER 2024 194
TABLE 190 COCHLEAR LTD.: DEALS, JANUARY 2021–DECEMBER 2024 194
TABLE 191 SONOVA: COMPANY OVERVIEW 196
TABLE 192 EXCHANGE RATES USED FOR CONVERSION OF CHF TO USD 197
TABLE 193 SONOVA: PRODUCTS OFFERED 198
TABLE 194 SONOVA: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024 198
TABLE 195 MED-EL MEDICAL ELECTRONICS: COMPANY OVERVIEW 200
TABLE 196 MED-EL MEDICAL ELECTRONICS: PRODUCTS OFFERED 200
TABLE 197 MED-EL MEDICAL ELECTRONICS: PRODUCT LAUNCHES,
JANUARY 2021–DECEMBER 2024 201
TABLE 198 MED-EL MEDICAL ELECTRONICS: DEALS, JANUARY 2021–DECEMBER 2024 201
TABLE 199 MED-EL MEDICAL ELECTRONICS: OTHER DEVELOPMENTS,
JANUARY 2021–DECEMBER 2024 202
TABLE 200 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 203
TABLE 201 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 203
TABLE 202 NEUBIO AG: COMPANY OVERVIEW 205
TABLE 203 NEUBIO AG: PRODUCTS OFFERED 205
TABLE 204 TODOC CO., LTD.: COMPANY OVERVIEW 206
TABLE 205 TODOC CO., LTD.: PRODUCTS OFFERED 206
TABLE 206 SHANGHAI LISTENT MEDICAL TECH CO., LTD.: COMPANY OVERVIEW 207
TABLE 207 SHANGHAI LISTENT MEDICAL TECH CO., LTD.: PRODUCTS OFFERED 207
LIST OF FIGURES
FIGURE 1 COCHLEAR IMPLANTS MARKET: SEGMENTS CONSIDERED &
GEOGRAPHICAL SPREAD 23
FIGURE 2 COCHLEAR IMPLANTS MARKET: YEARS CONSIDERED 24
FIGURE 3 COCHLEAR IMPLANTS MARKET: RESEARCH DESIGN 26
FIGURE 4 COCHLEAR IMPLANTS MARKET: KEY DATA FROM SECONDARY SOURCES 28
FIGURE 5 COCHLEAR IMPLANTS MARKET: KEY PRIMARY SOURCES 29
FIGURE 6 COCHLEAR IMPLANTS MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS 31
FIGURE 7 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 31
FIGURE 8 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 32
FIGURE 9 COCHLEAR IMPLANTS MARKET: REVENUE SHARE ANALYSIS 33
FIGURE 10 COUNTRY-BASED APPROACH FOR ESTIMATING GLOBAL MARKET SIZE 34
FIGURE 11 COCHLEAR IMPLANTS MARKET: APPROACH FOR ESTIMATING GLOBAL MARKET SIZE BASED ON UNITS SOLD 35
FIGURE 12 COCHLEAR IMPLANTS MARKET: CAGR PROJECTIONS (SUPPLY SIDE) 36
FIGURE 13 COCHLEAR IMPLANTS MARKET: TOP-DOWN APPROACH 37
FIGURE 14 COCHLEAR IMPLANTS MARKET: DATA TRIANGULATION 38
FIGURE 15 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE,
2024 VS. 2030 (USD MILLION) 41
FIGURE 16 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT,
2024 VS. 2030 (USD MILLION) 42
FIGURE 17 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2024 VS. 2030 (USD MILLION) 42
FIGURE 18 COCHLEAR IMPLANTS MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 43
FIGURE 19 COCHLEAR IMPLANTS MARKET: REGIONAL SNAPSHOT 44
FIGURE 20 INCREASING PATIENT POOL AND RISING HEALTHCARE
EXPENDITURE TO DRIVE MARKET 45
FIGURE 21 US AND COCHLEAR IMPLANT SYSTEMS COMMANDED
LARGEST MARKET SHARE IN 2023 46
FIGURE 22 CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030 47
FIGURE 23 ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING STUDY PERIOD 48
FIGURE 24 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 49
FIGURE 25 COCHLEAR IMPLANTS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 50
FIGURE 26 COCHLEAR IMPLANTS MARKET: VALUE CHAIN ANALYSIS 61
FIGURE 27 COCHLEAR IMPLANTS MARKET: SUPPLY CHAIN ANALYSIS 62
FIGURE 28 COCHLEAR IMPLANTS MARKET: ECOSYSTEM ANALYSIS 63
FIGURE 29 KEY PLAYERS IN COCHLEAR IMPLANTS MARKET ECOSYSTEM 63
FIGURE 30 COCHLEAR IMPLANTS MARKET: PORTER’S FIVE FORCES ANALYSIS 65
FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 67
FIGURE 32 KEY BUYING CRITERIA FOR MAJOR END USERS 68
FIGURE 33 PATENT ANALYSIS FOR COCHLEAR IMPLANTS, JANUARY 2014–DECEMBER 2024 77
FIGURE 34 COCHLEAR IMPLANTS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 81
FIGURE 35 COCHLEAR IMPLANTS MARKET: FUNDING AND NUMBER OF DEALS, 2020–2024 82
FIGURE 36 NORTH AMERICA: COCHLEAR IMPLANTS MARKET SNAPSHOT 124
FIGURE 37 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET SNAPSHOT 149
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN COCHLEAR IMPLANTS MARKET,
2021–2023 180
FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN COCHLEAR IMPLANTS MARKET (2023) 181
FIGURE 40 COCHLEAR IMPLANTS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 184
FIGURE 41 COCHLEAR IMPLANTS MARKET: COMPANY FOOTPRINT 185
FIGURE 42 EV/EBITDA OF KEY VENDORS 187
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 188
FIGURE 44 COCHLEAR IMPLANTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 188
FIGURE 45 COCHLEAR LTD.: COMPANY SNAPSHOT 192
FIGURE 46 SONOVA: COMPANY SNAPSHOT 197
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後2営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。
最新調査レポート
- 尿失禁デバイス市場 – 2030年までの世界予測 2025-03-12
- 医療用加湿器市場 – 2029年までの世界予測 2025-03-11
- BOPETフィルム市場 – 2029年までの世界予測 2025-03-11
- 金ナノ粒子市場 – 2029年までの世界予測 2025-03-07
- 沈降シリカ市場 – 2030年までの世界予測 2025-03-07